vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance Shares of vTv Therapeutics stock opened at $10.07 on Friday. The firm’s fifty day simple moving average is […]

Leave a Reply

Your email address will not be published.

Previous post Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com
Next post StockNews.com Begins Coverage on United-Guardian (NASDAQ:UG)